Journal of the American College of Radiology
Volume 7, Issue 2 , Pages 120-124 , February 2010

Quantifying Radiation Safety and Quality in Medical Imaging, Part 4: The Medical Imaging Agent Scorecard

  • Bruce I. Reiner, MD

      Affiliations

    • Corresponding Author InformationCorresponding author and reprints: Bruce I. Reiner, MD, Baltimore VA Medical Center, Department of Diagnostic Imaging, 22 N Greene Street, Baltimore, MD 21201

References 

  1. Henderson JA, Alexander BC, Smith JJ. The Food and Drug Administration and molecular imaging agents: potential challenges and opportunities. J Am Coll Radiol. 2005;2:833–840
  2. Hillman B, Neiman HL. Translating molecular imaging research into radiologic practice: summary of the proceedings of the American College of Radiology Colloquium, April 22-24, 2001. Radiology. 2002;222:19–24
  3. Food, Drug, and Cosmetic Act, Pub L No 75-717, 52 Stat 1040 (1938) (as amended 21 USC 301 et seq).
  4. US Food and Drug Administration. Biological products: general. 21 CFR 600.
  5. Morrison G, Odle TG. Safety considerations in contrast media handling and administration. https://www.asrt.org/media/pdf/educators/KM07WhtPprContrastSafetyFINAL2081307.pdfAccessed October 18, 2009
  6. E-Z-EM. Is your department still JCAHO compliant?. http://www.ezem.com/pdf/1304020_ctjcaho.pdfAccessed October 18, 2009
  7. Stevens CM. Regulatory compliance associated with contrast media. http://www.ahraonline.org/AM/Downloads/OnLineED/2005NovDec.pdfAccessed October 18, 2009
  8. Aspden P, Wolcott JA, Bootram JL. Preventing medical errors. Washington, DC: National Academies Press; 2007;
  9. Santell JP, Hicks RW, Cousins DD. MEDMARX data report: a chartbook of 2000-2004 findings from intensive care units and radiological services. Rockville, Md: MEDMARX; 2005;
  10. Katzberg RW, Haller C. Contrast-induced nephrotoxicity: clinical landscape. Kidney Int. 2006;69:53–57
  11. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002;39:930–936
  12. Bartholomew BA, Harjai KJ, Dukkipati S, et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol. 2004;93:1515–1519
  13. Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of ARF after percutaneous coronary intervention. Circulation. 2002;105:2259–2264
  14. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality: a cohort analysis. JAMA. 1996;275:1489–1494
  15. Newhouse JH, Kho D, Rao QA, Starren J. Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity. AJR Am J Roentgenol. 2008;191:378–382
  16. Bruce RJ, Djamali A, Shinki K, et al. Background fluctuation of kidney function versus contrast-induced nephrotoxicity. AJR Am J Roentgenol. 2009;192:711–718
  17. Halsted MJ, Racadio JM, Emery KH, et al. Oral contrast agents for CT of abdominal trauma in pediatric patients: a comparison of dilute Hypaque and water. AJR Am J Roentgenol. 2004;182:1555–1559
  18. Donnelly LF, Frush DP, Frush KS. Aspirated contrast material contributing to respiratory arrest in a pediatric trauma patient. AJR Am J Roentgenol. 1998;171:471–473
  19. Perez-Rodriguez J, Lai S, Ehst BD, et al. Nephrogenic systemic fibrosis: incidence, associations, and effect of risk factor assessment: report of 33 cases. Radiology. 2009;2:371–377
  20. Penfield JG. Nephrogenic systemic fibrosis and the use of gadolinium-based contrast agents. Pediatr Nephrol. 2008;12:2121–2129
  21. Stratta P, Canavese C, Aime S. Gadolinium-enhanced MRI, renal failure, and nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy. Curr Med Chem. 2008;12:1229–1235
  22. Dolan MS, Gala SS, Dodla S, et al. Safety and efficacy of commercially available ultrasound contrast agents for rest and stress echocardiography: a multi-center experience. J Am Coll Cardiol. 2009;53:32–38
  23. Main ML, Ryan AC, Davis TE, et al. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent. Am J Cardiol. 2008;12:1742–1746
  24. American College of Radiology. Home page. http://www.acr.orgAccessed October 18, 2009

PII: S1546-1440(09)00468-2

doi: 10.1016/j.jacr.2009.09.018

Journal of the American College of Radiology
Volume 7, Issue 2 , Pages 120-124 , February 2010

Article Tools